These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33316234)

  • 1. Identification of Distinct Immunophenotypes in Critically Ill Coronavirus Disease 2019 Patients.
    Dupont T; Caillat-Zucman S; Fremeaux-Bacchi V; Morin F; Lengliné E; Darmon M; Peffault de Latour R; Zafrani L; Azoulay E; Dumas G
    Chest; 2021 May; 159(5):1884-1893. PubMed ID: 33316234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of the Appropriate Control Group Is Essential in Evaluating the Cytokine Storm in COVID-19.
    Vassiliou AG; Dimopoulou I; Jahaj E; Keskinidou C; Mastora Z; Orfanos SE; Kotanidou A
    In Vivo; 2021; 35(2):1295-1298. PubMed ID: 33622933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
    Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
    Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
    Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
    Front Immunol; 2020; 11():581338. PubMed ID: 33123167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of Cardiac Injury in Critically Ill Patients With Coronavirus Disease 2019.
    Doyen D; Dupland P; Morand L; Fourrier E; Saccheri C; Buscot M; Hyvernat H; Ferrari E; Bernardin G; Cariou A; Mira JP; Jamme M; Dellamonica J; Jozwiak M
    Chest; 2021 May; 159(5):1974-1985. PubMed ID: 33129792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19.
    Chen Y; Wang J; Liu C; Su L; Zhang D; Fan J; Yang Y; Xiao M; Xie J; Xu Y; Li Y; Zhang S
    Mol Med; 2020 Oct; 26(1):97. PubMed ID: 33121429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients.
    Bülow Anderberg S; Luther T; Berglund M; Larsson R; Rubertsson S; Lipcsey M; Larsson A; Frithiof R; Hultström M
    Cytokine; 2021 Feb; 138():155389. PubMed ID: 33348065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperinflammation and Immune Response Generation in COVID-19.
    Mishra KP; Singh AK; Singh SB
    Neuroimmunomodulation; 2020; 27(2):80-86. PubMed ID: 33341814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal T lymphocyte homing is associated with gastric emptying and epithelial barrier function in critically ill: a prospective observational study.
    Greis C; Rasuly Z; Janosi RA; Kordelas L; Beelen DW; Liebregts T
    Crit Care; 2017 Mar; 21(1):70. PubMed ID: 28327177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System.
    Lipcsey M; Persson B; Eriksson O; Blom AM; Fromell K; Hultström M; Huber-Lang M; Ekdahl KN; Frithiof R; Nilsson B
    Front Immunol; 2021; 12():627579. PubMed ID: 33692801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Title: Cytokine release syndrome is not usually caused by secondary hemophagocytic lymphohistiocytosis in a cohort of 19 critically ill COVID-19 patients.
    Lorenz G; Moog P; Bachmann Q; La Rosée P; Schneider H; Schlegl M; Spinner C; Heemann U; Schmid RM; Algül H; Lahmer T; Huber W; Schmaderer C
    Sci Rep; 2020 Oct; 10(1):18277. PubMed ID: 33106497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of host endothelial, epithelial and inflammatory response in ICU patients with and without COVID-19: a prospective observational cohort study.
    Bhatraju PK; Morrell ED; Zelnick L; Sathe NA; Chai XY; Sakr SS; Sahi SK; Sader A; Lum DM; Liu T; Koetje N; Garay A; Barnes E; Lawson J; Cromer G; Bray MK; Pipavath S; Kestenbaum BR; Liles WC; Fink SL; West TE; Evans L; Mikacenic C; Wurfel MM
    Crit Care; 2021 Apr; 25(1):148. PubMed ID: 33874973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.
    Han H; Ma Q; Li C; Liu R; Zhao L; Wang W; Zhang P; Liu X; Gao G; Liu F; Jiang Y; Cheng X; Zhu C; Xia Y
    Emerg Microbes Infect; 2020 Dec; 9(1):1123-1130. PubMed ID: 32475230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
    Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
    J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Mobility Group Box 1 and Interleukin 6 at Intensive Care Unit Admission as Biomarkers in Critically Ill COVID-19 Patients.
    Sivakorn C; Dechsanga J; Jamjumrus L; Boonnak K; Schultz MJ; Dondorp AM; Phumratanaprapin W; Ratanarat R; Naorungroj T; Wattanawinitchai P; Siripoon T; Duangdee C; Techarang T
    Am J Trop Med Hyg; 2021 May; 105(1):73-80. PubMed ID: 33939645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Interleukin-6 Concentrations and the Severity of COVID-19 Pneumonia: A Retrospective Study at a Single Center in Bengbu City, Anhui Province, China, in January and February 2020.
    Sun H; Guo P; Zhang L; Wang F
    Med Sci Monit; 2020 Nov; 26():e926941. PubMed ID: 33175722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemoadsorption cartridge and coronavirus disease 2019 infections: A case report and brief literature review.
    Melegari G; Bertellini E; Melegari A; Trenti T; Malaguti S; Barbieri A
    Artif Organs; 2021 May; 45(5):E130-E135. PubMed ID: 33084021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Significance of Micronutrient Supplementation in Critically Ill COVID-19 Patients with Severe ARDS.
    Notz Q; Herrmann J; Schlesinger T; Helmer P; Sudowe S; Sun Q; Hackler J; Roeder D; Lotz C; Meybohm P; Kranke P; Schomburg L; Stoppe C
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34203015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019.
    Chen X; Zhao B; Qu Y; Chen Y; Xiong J; Feng Y; Men D; Huang Q; Liu Y; Yang B; Ding J; Li F
    Clin Infect Dis; 2020 Nov; 71(8):1937-1942. PubMed ID: 32301997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Characteristics and Predictors of 28-Day Mortality in 352 Critically Ill Patients with COVID-19: A Retrospective Study.
    Alharthy A; Aletreby W; Faqihi F; Balhamar A; Alaklobi F; Alanezi K; Jaganathan P; Tamim H; Alqahtani SA; Karakitsos D; Memish ZA
    J Epidemiol Glob Health; 2021 Mar; 11(1):98-104. PubMed ID: 33095982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.